Literature DB >> 8137090

Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid.

T Terao1, T Mizuki, T Ohji, K Abe.   

Abstract

Two depressive patients with systemic lupus erythematosus (SLE) and cerebral infarction, while being treated with corticosteroid, are described. In both cases, lithium was remarkably effective and no severe side-effects occurred. These findings suggest that lithium can be a useful antidepressant agent in the treatment of depressive SLE patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137090     DOI: 10.1192/bjp.164.1.109

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

Review 1.  Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.

Authors:  S B Patten; C I Neutel
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 2.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

3.  Depression as an initial feature of systemic lupus erythematosus? A case report.

Authors:  Gabriela Marian; Elena Alina Nica; Brindusa Ecaterina Ionescu; Doina Gabriela Carlogea
Journal:  J Med Life       Date:  2010 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.